Consequently, the oxidized nicotinamide adenine dinucleotide/ATP ratio is depleted, and glyceraldehyde-3-phosphate dehydrogenase is inactivated, leading to the activation of harmful pathways such as the polyol, hexosamine and protein kinase C (PKC) pathways, as well as the subsequent accumulation of advanced glycation end products, resulting in microvascular damage
These effects were commonly observed not only among diabetes patients but also in individuals utilizing GLP-1 RA Medicationss for weight loss, indicating a common trend with new medications designed for weight management
T., Golenbock, D
However, clinical observations and trial data have identified specific circumstances where these drugs may be associated with worsening diabetic retinopathy, particularly in patients with pre-existing retinal disease
The primary measures used to evaluate the drugs effects were changes in the patients scores on the Unified Parkinson Disease Rating Scale (UPDRS), which measures their ability to perform daily activities and motor function